Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8XCOVERY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 10899744

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code : U-4099

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-01

blank

02

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 10899744

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code : U-4099

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-01

blank

03

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 9296724

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code : U-4099

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-18

blank

04

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 9296724

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code : U-4099

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-18

blank

05

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 9126947

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-29

blank

06

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 8551995

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-02-09

blank

07

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 8551995

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-02-09

blank

08

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

ENSARTINIB HYDROCHLORIDE

US Patent Number : 9126947

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218171

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-29

blank